Newsletter

FOR IMMEDIATE RELEASE BioMedSA Names Dr. Donald H. Jenkins the 2026 Innovative Clinical Care Award Recipient (SAN ANTONIO, TEXAS) — July 1, 2026 — BioMedSA announced today that Donald H. Jenkins, MD, FACS, Professor of Surgery and Vice Chair for Quality at UT Health San Antonio, has been selected as the 2026 BioMedSA Innovative Clinical … Read more

Robert A. Clark, MD, Ashbel Smith Professor of Medicine and Associate Vice President for Translational Science at UT Health San Antonio, has been selected as the 2026 BioMedSA BioMedSA Research Innovation Award recipient. The honor recognizes his five decades of groundbreaking discoveries and his transformational leadership in building San Antonio’s biomedical research infrastructure. Dr. Clark’s … Read more

Championing the biomedical industry and its contributions to the lives of the citizens of San Antonio, BioMedSA has selected its 2026 Entrepreneur Award recipient. BioMedSA named Dr. James R. “Jim” Leininger as this year’s honoree, recognizing a physician‑innovator whose work transformed wound care, strengthened the region’s biomedical economy, and helped define San Antonio’s identity as … Read more

BioMedSA’s Board of Directors approved 2 new memberships in April 2026:  Bartlett Cocke General Contractors and Cizzle Bio. Bartlett Cocke General Contractors is a Texas‑based construction firm recognized for its extensive work in healthcare and clinical environments. The company has delivered a wide range of medical facilities, including hospitals, imaging centers, surgical suites, and specialized … Read more

BioMedSA’s Board of Directors approved 2 new memberships in April 2026:  Rees Scientific and Rogel Associates. Rees Scientific provides automated environmental monitoring systems designed to continuously track critical conditions such as temperature, humidity, differential pressure, CO₂ levels, and other environmental variables. These systems are commonly used in regulated environments where maintaining stable conditions is essential … Read more

BioMedSA’s Board of Directors approved 2 new members in March 2026: Eich, Inc. and Integral LifeScience Advisors. Integral LifeScience Advisors is a consulting firm that supports life‑science and healthcare companies across multiple stages of development. The firm provides medical and clinical expertise, including clinical development planning, evidence generation strategy, and support for interactions with healthcare stakeholders. … Read more

BioMedSA’s Board of Directors approved 3 new memberships in February 2026: Cardivox AI, Joeris General Contractors, and TruCells. Cardivox AI is developing an AI‑driven platform designed to analyze cardiovascular health using ECG and heart‑rate data. The system incorporates machine‑learning algorithms to estimate metrics such as blood pressure and identify potential cardiac risks. It integrates with … Read more

Lori Boies, Ph.D., MPH, has made significant contributions to the fields of bioinformatics, cancer biology, public health, and science education. Her early research at UT Southwestern advanced neuro-oncology by developing and characterizing two novel inducible transgenic mouse models, leading to the identification of distinct populations of adult neural stem cells and transient progenitors that persist … Read more

Medical genomics plays an increasingly important role in the life sciences, informing advances in research, diagnostics, and therapeutic development.  By examining how genetic variation influences disease risk, treatment response, and health outcomes, genomics is transforming how biomedical research is conducted and how new diagnostics and therapies are developed.  What was once confined to specialized research … Read more